← Eichor
Condition: Tenecteplase Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tenecteplase

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Randomization to Extend Stroke Intravenous ThromboLysis In Evolving Non-Large Vessel Occlusion With TNK (RESILIENT
Phase 3 · 15 location(s) · Hospital Moinhos de Vento · NCT05199662
Stereotactic Thrombolysis With Tenecteplase for Supratentorial Intracerebral Hemorrhage
NA · 2 location(s) · Tongji Hospital · NCT07208097
Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake
Phase 4 · 14 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06571149
Tenecteplase for Acute Ischemic Stroke Within 4.5 to 6 Hours of Onset (EXIT-BT2)
Phase 4 · 2 location(s) · General Hospital of Shenyang Military Region · NCT06010628
CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection
Phase 3 · 2 location(s) · Huashan Hospital · NCT06994975
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
Phase 4 · 1 location(s) · Xuanwu Hospital, Beijing · NCT07203625
Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Mediu
Phase 2/Phase 3 · 1 location(s) · Xiang Luo · NCT07302854
Extending the Time Window for Intravenous Tenecteplase in Patients With Distal Medium Vessel Occlusions Stroke
NA · 1 location(s) · The First Affiliated Hospital of University of Science and T · NCT06559436
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe
Phase 3 · 246 location(s) · Boehringer Ingelheim · NCT07361302
A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Is
Phase N/A · 1 location(s) · Xuanwu Hospital, Beijing · NCT07419997
ACT-GLOBAL Adaptive Platform Trial for Stroke
Phase 3 · 2 location(s) · The George Institute · NCT06352632
Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
Phase 3 · 1 location(s) · Beijing Tiantan Hospital · NCT07357987
Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke
Phase 3 · 1 location(s) · Xuanwu Hospital, Beijing · NCT06658197
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ
Phase 3 · 1 location(s) · Beijing Tiantan Hospital · NCT06414499
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Phase N/A · 33 location(s) · Insel Gruppe AG, University Hospital Bern · NCT06556446
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND
Phase 3 · 1 location(s) · Beijing Tiantan Hospital · NCT06954155
rhTNK-tPA Thrombolytic Removal of Intraventricular Hemorrhage
Phase 1 · 1 location(s) · Beijing Tiantan Hospital · NCT06814964
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06904911
A Real-world Study of Tenecteplase Versus Alteplase for Thrombolysis in Patients Within 4.5 H of Onset of Ischemic Strok
Phase N/A · 1 location(s) · Tianjin Huanhu Hospital · NCT06621121
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Phase 2/Phase 3 · 17 location(s) · University of Melbourne · NCT05105633
Randomization to Endovascular Treatment Alone or Preceded by Systemic Thrombolysis With Tenecteplase in Ischemic Stroke
Phase 3 · 13 location(s) · Hospital Moinhos de Vento · NCT05199194
Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage
Phase 3 · 1 location(s) · Beijing Tiantan Hospital · NCT06868511
Study on the Thrombolytic Effect of Platelet Membrane Coated Tenecteplase on Human Arterial Thrombus
Phase N/A · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT07712445
Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT
Phase 4 · 1 location(s) · Mahidol University · NCT06498323
Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients
Phase 4 · 51 location(s) · Southwest Hospital, China · NCT07294209
rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window
Phase 3 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07606807
Early Administration of Tirofiban in Patients Treated With Tenecteplase for Acute Ischemic Stroke
Phase 3 · 38 location(s) · Second Affiliated Hospital of Guangxi Medical University · NCT05604638
ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632
Phase 3 · 24 location(s) · University of Calgary · NCT06320431
Thrombolysis in Factor Xa-inhibitors Trial
Phase 3 · 13 location(s) · Guri Hagberg · NCT06878066
Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in China
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT07271342
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.